Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Obesity 3Urologic Neoplasms 1Stomach Neoplasms 1Smoking 1Sarcopenia 1Risk Reduction Behavior 1Rectal Neoplasms 1Postoperative Complications 1Patient Preference 1Overweight 1Motor Activity 1Malnutrition 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Alcohol Drinking 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Adiposity × Clear all
NCT06606912 2024-09-23

Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients

First Affiliated Hospital of Chongqing Medical University

Active not recruiting
4,000 enrolled
GastrointestinalOther

Gastrointestinal Neoplasms, Obesity, Stomach Neoplasms, Colorectal Neoplasms, Overweight, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡